Advancements in Tuberculosis (TB) Diagnosis
The past decade has witnessed significant innovations in the TB diagnostic landscape, which are crucial for global efforts to eliminate TB. Recent advancements include the introduction and WHO endorsement of new near point-of-care molecular tests and the use of tongue swab samples for TB diagnosis. These developments aim to improve testing efficiencies at scale.
Technological Innovations
- Portable Chest X-Ray (CXR) and AI: Portable CXR machines are now available under the National TB Elimination Programme in India, enabling community-level TB screening. AI solutions enhance the screening process by swiftly identifying suspicious lesions.
- Active case finding is facilitated through mobile vans equipped with portable CXR units.
- AI presents options for opportunistic screening across India’s healthcare settings.
- Molecular Testing: India has scaled up molecular testing with the adoption of CBNAAT and the indigenous Truenat. However, the accessibility of molecular testing remains uneven.
- WHO endorses near point-of-care nucleic acid amplification tests (nPOC-NAAT), expanding options for primary-care level testing.
- Use of non-sputum samples like tongue swabs is beneficial for those unable to produce sputum.
Challenges and Opportunities
- Diagnostic Cascade: Ensuring efficient sputum collection and reducing delays in drug resistance testing is vital to completing the diagnostic cascade promptly.
- Innovation and Research Needs:
- Development of cost-effective biomarkers for TB infection prediction.
- Innovations in diagnosing asymptomatic TB through less invasive tools.
- Enhanced diagnostics for pediatric TB and extra-pulmonary TB (EP-TB).
Strategic Implementation
India needs to conduct robust implementation research to test new diagnostic tools in specific settings. This involves developing clear diagnostic algorithms and streamlining innovation assessment and procurement pathways. The Indian Council of Medical Research plays a critical role in evaluating and recommending these tools.
Community Engagement and Public Health Impact
Investing in community-led programs is essential to drive demand for new diagnostic tools. Early diagnosis not only improves treatment outcomes but also reduces TB transmission within communities. A well-expanded diagnostic toolbox can significantly reduce the financial burden on families and accelerate TB elimination efforts in India.
Dr. Soumya Swaminathan, Chairperson of the M.S. Swaminathan Research Foundation, emphasizes that strategic investments in TB diagnostics can yield significant returns for the public health system.
